These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6766089)

  • 21. Characterization of macrophage functions in mice infected with Brucella abortus.
    Birmingham JR; Jeska EL
    Infect Immun; 1981 Jun; 32(3):1079-83. PubMed ID: 6788706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG-induced macrophage suppression in mice: suppression of specific and nonspecific antibody-medicated and cellular immunologic responses.
    Schrier DJ; Allen EM; Moore VL
    Cell Immunol; 1980 Dec; 56(2):347-56. PubMed ID: 7471219
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary study of two inbred mice models for infection and immunity of Brucellosis].
    Zhang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):18-24. PubMed ID: 2527626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein.
    Baloglu S; Boyle SM; Vemulapalli R; Sriranganathan N; Schurig GG; Toth TE
    Vet Microbiol; 2005 Aug; 109(1-2):11-7. PubMed ID: 15941627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular responses to "brucelline INRA" during the experimental brucellosis of the mouse.
    Bureau JP; Caravano R; Garelli L; Lemaire J
    Immunobiology; 1989 Mar; 179(1):8-16. PubMed ID: 2659500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced primary resistance to Listeria monocytogenes in T cell-deprived mice.
    Chan C; Kongshavn PA; Skamene E
    Immunology; 1977 Apr; 32(4):529-37. PubMed ID: 415965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308.
    Fernandes DM; Jiang X; Jung JH; Baldwin CL
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):193-203. PubMed ID: 9116636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of BALB/c mice with Brucella abortus 2308ΔwbkA confers protection against wild-type infection.
    Li ZQ; Gui D; Sun ZH; Zhang JB; Zhang WZ; Zhang H; Guo F; Chen CF
    J Vet Sci; 2015; 16(4):467-73. PubMed ID: 26040616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the novel triazinium zwitterion 1-methyl-3-phenyl-1,2,4-triazinium-5-olate on immunological responses and experimental brucellosis in mice.
    Zeng TS; Halliday WJ; Jacobsen NW; Seow WK; Thong YH
    Int J Immunopharmacol; 1991; 13(2-3):135-40. PubMed ID: 1906435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors.
    Zhan Y; Cheers C
    J Immunol; 1998 Aug; 161(3):1447-53. PubMed ID: 9686610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains.
    Sathiyaseelan J; Jiang X; Baldwin CL
    Clin Exp Immunol; 2000 Aug; 121(2):289-94. PubMed ID: 10931144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549.
    Hsieh CS; Macatonia SE; Tripp CS; Wolf SF; O'Garra A; Murphy KM
    J Immunol; 2008 Oct; 181(7):4437-9. PubMed ID: 18802044
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunology of antituberculous immunity.
    Mackaness GB
    Am Rev Respir Dis; 1968 Mar; 97(3):337-44. PubMed ID: 4966267
    [No Abstract]   [Full Text] [Related]  

  • 34. Depletion of Complement Enhances the Clearance of Brucella abortus in Mice.
    González-Espinoza G; Barquero-Calvo E; Lizano-González E; Alfaro-Alarcón A; Arias-Gómez B; Chaves-Olarte E; Lomonte B; Moreno E; Chacón-Díaz C
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice.
    Preston PM; Behbehani K; Dumonde DC
    J Clin Lab Immunol; 1978 Nov; 1(3):207-19. PubMed ID: 387961
    [No Abstract]   [Full Text] [Related]  

  • 36. A functional relationship between delayed hypersensitivity and antibacterial immunity.
    MacDonald TT; Carter PB
    Immunol Commun; 1981; 10(7):591-9. PubMed ID: 6800935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation.
    Wei P; Cui G; Lu Q; Yang L; Guan Z; Sun W; Zhao Y; Wang S; Peng Q
    Vet Microbiol; 2015 Jan; 175(1):50-7. PubMed ID: 25433453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.
    MACKANESS GB
    J Exp Med; 1964 Jul; 120(1):105-20. PubMed ID: 14194388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to brucella infection.
    Elberg SS
    Medicine (Baltimore); 1973 Jul; 52(4):339-56. PubMed ID: 4198657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.